M A Y 2 1, 2 0 1 2

Cerecor raises $22M

Learn more

OpGen nabs $17M for microbial genome mapping device

Learn more

Putting the President's National Bioeconomy Blueprint to work

Learn more

Advancing Next Generation of Vaccines

Dr. Arthur Friedlander is paving the way for the next generation of vaccines. Senior Scient U.S. Army Medical Research Institute of Infectious Diseases, Friedlander directed a team developed a new anthrax vaccine that worked in animal models and led to the developmen vaccines that are in human clinical trials under the National Institutes of Health. He also le research efforts to develop a new plague vaccine that is now in human clinical trials. In ho work, Friedlander has been nominated for the Samuel J. Heyman Service to America Med

New Cancer Center Breaks Ground

The University of Maryland School of Medicine and Advanced Particle Therapy of San Die ground last month on the new $200 million proton treatment center in Baltimore. The cente focus on proton therapy, an advanced technology that allows cancer patients to receive do radiation directly to their tumors without damaging the surrounding tissue or vital organs. S to open in 2014, the center will be one of only 12 places in the nation and the first in the re offer this cutting edge cancer-fighting technology.

Creating a World Free of AIDS

Gaithersburg-based GlycoMimetics is partnering with the International AIDS Vaccine Initia and Glycosensors and Diagnostics to develop a new AIDS vaccine that will use compound mimic carbohydrates, called glycomimetics. The partners hope to develop carbohydrate immunogens that stimulate the creation antibodies capable of fighting HIV. The project wil funded by IAVIs Innovation Fund, a program launched to support the application of novel unconventional technologies to AIDS vaccine design and development.

Tax Credit Applications Available Online

June 1 | Baltimore The Biotechnology Investment Incentive Tax Credit applications will be available June 1, 2012. DBED will be accepting applications to enable participation in the electronic filing process that will take place on July 2, 2012. Revised regulations are currently under review. Applications submitted during FY 2013 will be processed using existing regulations. Learn more.

The French Biotech Tour May 24 | Philadelphia, PA

The French Biotech Tour 2012 will focus on biomarker and personalized medicine. This unique one-day opportunity is FREE for US-based companies and includes pre-arranged, one-on-one business meetings, presentations from cutting-edge companies in their field and networking opportunities. Learn more.

Incubator of the Year Awards June 14 | Center Club, Baltimore

The 2012 Maryland Incubator Company of the Year Awards publicly recognizes achievements by current clients and graduates of Maryland incubators and provides a forum for the nominees to increase their visibility in the business, technology and investment communities. Learn more.